Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Check the medicine vial
Unlike previous research peptides, Retatrutide is a triple-agonist, uniquely designed to target three key receptors involved in metabolic regulation: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and the glucagon receptor
A critical analysis of the clinical use of incretin-based therapies
Easyjust notify us
Retching is a strong involuntary unproductive effort to vomit associated with abdominal muscle contraction but without expulsion of gastric contents through the mouth
Following the standard escalation, your first 10mg vial provides approximately 12 to 14 weeks of supply (through the 0.25 mg, 0.50 mg, and 1.0 mg phases)
US$ 25.19
US$ 22.00
US$ 20.82
US$ 22.32
US$ 22.38
